4D Molecular Therapeutics... (FDMT)

3.33

-0.01 (-0.30%)

At close: Apr 28, 2025, 3:59 PM

3.36

0.75%

After-hours: Apr 28, 2025, 05:29 PM EDT

4D Molecular Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q1 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Mar 31, 2018
Cash & Equivalents	149.34M	187.54M	189.06M	275.59M	249.11M	275.68M	310.34M	201.86M	52.35M	108.3M	113.48M	75.97M	153M	90.99M	243.74M	259.87M	276.73M	88.75M	-49.65M	49.65M	-72.87M	72.87M	72.87M	91.76M	91.76M	-23.85M
Short-Term Investments	275.54M	314.35M	352.88M	250.32M	39.12M	43.99M	74.03M	121.89M	161.2M	119.42M	127.6M	160.18M	94.78M	70.69M	n/a	n/a	n/a	n/a	99.3M	n/a	145.74M	n/a	n/a	n/a	n/a	47.7M
Long-Term Investments	80.58M	48.78M	35.72M	62.94M	10.95M	n/a	n/a	1.41M	4.91M	11.12M	20.53M	48.36M	67.65M	65.49M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.26M	2.86M	2.32M	771K	684K	682K	8.51M	1.26M	1.08M	1.05M	963K	875K	602K	602K	602K	602K	602K	675K	-49.65M	677K	-72.87M	1.03M	1.03M	429K	429K	-23.85M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47K	791K	1.22M	965K	1.49M	896K	n/a	978K	n/a	1.16M	1.16M	1.12M	1.12M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-700K	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	1.00	n/a	n/a	n/a
Other Current Assets	10.05M	8.87M	10.69M	9.68M	8.36M	8.58M	7.43M	6.59M	6.96M	4.76M	5.43M	6.89M	n/a	3.27M	3.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	400K	n/a
Total Current Assets	434.93M	510.76M	552.63M	535.59M	296.59M	328.24M	310.34M	207.04M	220.51M	232.48M	246.52M	243.05M	256.28M	165.73M	248.75M	264.5M	282.66M	92.54M	49.65M	52.51M	72.87M	75.44M	75.44M	94.07M	94.07M	23.85M
Property-Plant & Equipment	40.61M	41.63M	29.45M	30.58M	31.66M	32.69M	33.65M	34.32M	35.35M	35.51M	34.92M	32.64M	28.95M	8.79M	5.58M	5.01M	5.07M	4.98M	n/a	5.05M	n/a	4.03M	4.03M	2.47M	2.47M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	125.45M	93.27M	67.48M	94.29M	43.3M	33.37M	42.16M	36.98M	41.34M	47.69M	56.41M	81.88M	97.21M	74.89M	6.18M	5.61M	5.67M	5.66M	-49.65M	5.73M	-72.87M	5.05M	5.05M	2.9M	2.9M	-23.85M
Total Assets	560.38M	604.03M	620.12M	629.88M	339.89M	361.61M	352.5M	244.02M	261.85M	280.16M	302.94M	324.93M	353.49M	240.62M	254.93M	270.11M	288.33M	98.19M	n/a	58.23M	n/a	80.5M	80.5M	96.97M	96.97M	n/a
Account Payables	4.39M	2.92M	3.43M	4.22M	3.52M	4.71M	3.49M	2.41M	3.32M	1.48M	3.32M	2.68M	4.76M	3.71M	1.96M	1.28M	1.79M	1.29M	n/a	1.74M	n/a	1.11M	1.11M	954K	954K	n/a
Deferred Revenue	257K	35K	n/a	1.32M	273K	130K	576K	778K	884K	2.21M	2.26M	2.11M	2.6M	1.73M	3.02M	7.09M	6.59M	5.62M	n/a	5.86M	n/a	4.25M	n/a	4.91M	n/a	n/a
Short-Term Debt	n/a	n/a	3.2M	n/a	n/a	3.13M	3.1M	n/a	n/a	2.63M	2.6M	2.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	4.09M	4.5M	n/a	1.69M	-968K	n/a	n/a	900K	1.27M	610K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	181K	4.43M	n/a	4.91M	n/a
Total Current Liabilities	29.15M	29.46M	19.4M	16.4M	18.95M	18.16M	13.75M	11.28M	15.73M	13.56M	14.33M	12.09M	16.34M	11.37M	9.87M	13.92M	16.74M	14.28M	n/a	12.96M	n/a	8.6M	8.6M	8.05M	8.05M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	603K	1.87M	596K	600K	617K	389K	236K	248K	233K	236K	234K	236K	334K	2.1M	2.08M	2.08M	1.97M	13.76M	n/a	104.65M	n/a	103.42M	n/a	103.43M	n/a	n/a
Total Long-Term Liabilities	20.63M	21.61M	12.37M	12.92M	13.11M	13.52M	13.61M	14.14M	14.78M	15.16M	16.09M	16.78M	18.04M	5.11M	4.42M	13.77M	15.2M	13.76M	n/a	118.25M	n/a	114.2M	n/a	116.5M	n/a	n/a
Total Liabilities	49.78M	51.08M	31.78M	29.32M	32.06M	31.68M	725.29M	25.41M	30.51M	28.72M	30.42M	28.87M	34.38M	16.48M	14.29M	27.68M	31.94M	28.04M	n/a	131.2M	n/a	122.8M	8.6M	124.56M	8.05M	n/a
Total Debt	24.61M	24.83M	13.66M	14.17M	14.67M	15.16M	15.63M	15.68M	16.12M	16.55M	17M	16.82M	16.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	5K	5K	5K	5K	4K	4K	4K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	2K	n/a	1K	n/a	1K	1K	1K	1K	n/a
Retained Earnings	-576.2M	-526.52M	-482.68M	-447.73M	-415.33M	-383.04M	-372.79M	-343.17M	-314.49M	-287.11M	-261.42M	-233.33M	-207M	-181.91M	-159.67M	-152.09M	-135.68M	-115.13M	n/a	-79.03M	n/a	-46.23M	-46.23M	-30.03M	-30.03M	n/a
Comprehensive Income	229K	n/a	-293K	-109K	16K	534K	345K	-270K	-1.2M	-1.85M	-1.83M	-1.42M	-423K	-195K	n/a	0.00	0.00	-175.45M	-72.97M	-102.98M	-42.3M	-102.98M	n/a	-102.98M	n/a	-19.59M
Shareholders Equity	510.61M	552.95M	588.34M	600.56M	307.83M	329.93M	-372.79M	-343.17M	231.34M	251.44M	272.52M	296.06M	319.11M	224.13M	240.65M	242.43M	256.39M	70.16M	30.01M	-72.97M	60.68M	-42.3M	60.68M	-27.59M	75.39M	-1.08M
Total Investments	356.12M	363.13M	388.6M	313.26M	50.08M	43.99M	74.03M	123.29M	166.11M	130.54M	148.14M	208.54M	162.43M	136.18M	n/a	n/a	n/a	n/a	99.3M	n/a	145.74M	n/a	n/a	n/a	n/a	47.7M